John Thompson
Director/Board Member at NERVGEN PHARMA CORP.
Net worth: - $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William Radvak | M | 61 | 7 years | |
| Bradley Margus | M | 63 |
Cerevance, Inc.
 Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | 8 years |
| Harold Punnett | M | 67 | 7 years | |
| Michael Kelly | M | 59 | 1 years | |
| Sally Susman | F | 62 | 17 years | |
| Adam Rogers | M | - | 2 years | |
| Krista McKerracher | F | - | 3 years | |
| Mark Carlton | M | - |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | 8 years |
| Suzanne Johnson | F | 66 | 17 years | |
| Brian Bayley | M | 71 | 6 years | |
| Glenn Ives | M | 62 | 3 years | |
| Aoife Brennan | M | 48 |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | 4 years |
| Mike McDermott | M | 58 | 21 years | |
| Daniel Mikol | M | - | 3 years | |
| Markus Green | M | - | 18 years | |
| Matthias Kleinz | M | - |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | - |
| Annaliesa Anderson | M | - | 17 years | |
| Laurence Barker | M | - |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | - |
| Huitt Tracey | M | 64 | - | |
| Robert Poole | M | 67 |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | 3 years |
| John Ruffolo | M | - | 1 years | |
| Stephen Hitchcock | M | - |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | - |
| Randall Kaye | M | 61 | 4 years | |
| Mikael Dolsten | M | 65 | 15 years | |
| Jason Lettmann | M | 46 |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | - |
| David Lubner | M | 60 |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | 4 years |
| Bill Adams | M | 62 | 4 years | |
| Barbara Dalton | M | 69 | 17 years | |
| Sourav Kole | M | - |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Larry G. Edwards | M | 52 | 5 years | |
| Henry McKinnell | M | 81 | 8 years | |
| Paul A. Brennan | M | - | 3 years | |
| David Shedlarz | M | 75 | 31 years | |
| Amy Schulman | F | 63 | 6 years | |
| Dennis Ausiello | M | 78 | 13 years | |
| Alan Levin | M | 62 | 20 years | |
| Mace Rothenberg | M | 67 | 13 years | |
| Steve Gullans | M | 71 | 5 years | |
| Robert Landry | M | 60 | 4 years | |
| Paul Fitzhenry | M | 63 | 4 years | |
| John Mascotte | M | 84 | 4 years | |
| Colin Hislop | M | 66 | 11 years | |
| Maria D. Stahl | F | 53 | 5 years | |
| Brent Furse | M | 55 | - | |
| Jacob M. Plotsker | M | 56 | 16 years | |
| Everett Cunningham | M | 57 | 9 years | |
| Ranjeev Krishana | M | 50 | 7 years | |
| Jeffrey Chodakewitz | M | 68 | 6 years | |
| Alexandra Kropotova | M | 51 | 5 years | |
| Martin MacKay | M | 68 | 14 years | |
| Yi Ning Zhao | M | 53 | 8 years | |
| Stephen W. Sanger | M | 78 | 9 years | |
| Gerri Henwood | F | 71 | 5 years | |
| Nancy Wysenski | F | 66 | 6 years | |
| Michael R. Jirousek | M | 65 | 5 years | |
| Freda Lewis-Hall | M | 69 | 11 years | |
| Frances Fergusson | M | 79 | 9 years | |
| James Kilts | M | 76 | 13 years | |
| Peter Corr | M | 76 | 6 years | |
| Steven Engle | M | 69 | 3 years | |
| Frank D'Amelio | M | 66 | 14 years | |
| Sanford Zweifach | M | 68 | 3 years | |
| Michael Jeffrey Abrams | M | 68 | 4 years | |
| Reina Benabou | M | 60 | 4 years | |
| Adrian Otte | M | - | 6 years | |
| Mark J. Taisey | M | - | 5 years | |
| Lee Golden | M | 56 | 4 years | |
| Muriel Cottard | M | - | 4 years | |
| Robyn Peters | F | - | 4 years | |
| Carl Morris | M | 54 | 5 years | |
| Valerie L. Legagneur | F | 50 | 10 years | |
| William S. Korinek | M | - | 9 years | |
| Daniel Karp | M | 46 | 12 years | |
| Hong I. Wan | M | - | 5 years | |
| Hua Gong | M | 57 | 10 years | |
| Glenn Miles | M | 58 | 4 years | |
| Jeffrey Kent | M | 62 | 4 years | |
| Lit-Fui Lau | M | 62 | 10 years | |
| Margaret Marshall | M | 67 | 8 years | |
| James R. Thomas | M | 73 | 19 years | |
| John Porter | M | 53 | 5 years | |
| Eliot Forster | M | 58 | 11 years | |
| Neil Gibson | M | 67 | 4 years | |
| Walter S. Hauck | M | 64 | 13 years | |
| John C. Kelly | M | 81 | 1 years | |
| Jean-Michael Halfon | M | 72 | 21 years | |
| William Sigmund | M | - | 4 years | |
| Linda Armstrong | M | 61 | 6 years | |
| William H. D. Horton | M | - | 1 years | |
| Martine George | M | 76 | 5 years | |
| Valerie Start | M | 64 | 3 years | |
| William J. Slichenmyer | M | 66 | 7 years | |
| Loretta Ucelli | F | - | - | |
| Eduardo Von Pervieux | M | - | 6 years | |
| Scott Cheshareck | M | - | 16 years | |
| Ronald Green | M | 63 | 12 years | |
| Krishan K. Arora | M | 83 | 5 years | |
| James H. Heym | M | - | 24 years | |
| Anna Berkenblit | M | 54 | 4 years | |
| Michael Loechel | M | - | 11 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 86 | 86.00% |
| Canada | 14 | 14.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John Thompson
- Personal Network
